InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Kalin Katherine Bach. Officer active across 1 company, notably SELLAS Life Sciences Group, Inc.. Cumulatively, 6 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €119k. Activity tracked since 2 February 2023. The latest transaction was filed on 7 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Kalin Katherine Bach is a declarant with 6 filings in total. The 6 sampled filings concern SELLAS Life Sciences Group, Inc. (XNAS), where she is Director, and cover the period from 2023-02-03 to 2026-01-09. Across these recent filings, the reported buy amount is EUR 118953 and the reported sell amount is EUR 0, with modal transaction nature Attribution.